跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LANOTAN OPHTHALMIC SOLUTION 0.005% w/w - HSA Drug Approval Details
Approvals
/
HSA
/
LANOTAN OPHTHALMIC SOLUTION 0.005% w/w
Approved
THERAPEUTIC
LANOTAN OPHTHALMIC SOLUTION 0.005% w/w
BAUSCH & LOMB INCORPORATED (TAMPA) (UNITED STATES)
🇸🇬 Health Sciences Authority
Approval Date
Aug 27, 2013
Approval ID
9f8dd5470c57cdf5
Company
BAUSCH & LOMB INCORPORATED (TAMPA) (UNITED STATES)
Type
Therapeutic
Approval Details
Approval Id
9f8dd5470c57cdf5
Drug Name
LANOTAN OPHTHALMIC SOLUTION 0.005% w/w
Product Name
LANOTAN OPHTHALMIC SOLUTION 0.005% w/w
Approval Number
SIN14399P
Approval Date
2013-08-27
Registrant
BAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED
Licence Holder
BAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
SOLUTION
Route Of Administration
OPHTHALMIC
Atc Code
S01EE01
Atc Item Name
latanoprost
Pharma Manufacturer Name
BAUSCH & LOMB (SINGAPORE) PRIVATE LIMITED
Active Ingredients
LATANOPROST
0.005% w/w
LATANOPROST
0.005% w/w
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 27, 2013
Approval ID
9f8dd5470c57cdf5
Type
Therapeutic
Back to HSA Approvals